Posts by Brian Westerlind
Little-Known Facts About 3 Unique Starting Materials
By Mary Beth Watkins and Eric Foxman The array of substances used for homeopathic drug products is wide and varied. Many homeopathic starting materials also have uses outside of…
Read MoreState of Homeopathic Medicines at Retail
By Mark Land, AAHP President Every year or so I survey my local CVS store for the number and type of homeopathic drug products on their shelves. This year…
Read MoreHomeopathic Manufacturers Support FDA’s Revised Draft Guidance as Continuing Legal Status of Homeopathic Drugs
MILWAUKIE, Ore., Oct. 25, 2019 — Yesterday, the U.S. Food and Drug Administration (FDA) released a revised draft of a proposed guidance on homeopathic drugs and officially withdrew the 1988…
Read MoreClearing the Air: Consider Slack-Fill
By Mark Land, AAHP President Although the term might not be familiar, you may have been fooled by “slack-fill” as a consumer of many types of products at one…
Read MoreThe Amazon Deal You Never Heard Of
By Ray Petrick, VP of Sales, Boiron USA Amazon’s accelerator program has existed for almost a year, and you’ve probably never heard of it. Amazon Accelerator gives sellers prominent…
Read MoreYour Products Might Require Child-Resistant Packaging Statements
If so, they must comply with both CPSC and FDA requirements. Consumer Product Safety Commission (CPSC) Requirements CPSC is responsible for enforcing the Poison Prevention Packaging Act (PPPA). Introduced in…
Read MoreWhy It’s Crucial to Monitor FDA Guidances
By Mark Land, AAHP President It can take several years for manufacturers to implement new guidelines from the Food and Drug Administration (FDA)—and that means they could be at risk…
Read MoreAustralia to Release the First Draft Report on Homeopathy Effectiveness
By Mark Land, AAHP President Many believe the draft report arrived at a more encouraging conclusion regarding the effectiveness of homeopathy and may have been suppressed by the then…
Read MoreAlert: FDA Drug Listing Records Subject to Inactivation
By Eric Foxman, AAHP Secretary Beginning September 14, 2019, and every January, FDA will begin to inactivate drug listings that are uncertified in the previous renewal period. Last month,…
Read More2020 Democratic Presidential Run
By Pete Evich, AAHP Government Relations As the 2020 U.S. presidential election inches closer, many Democratic hopefuls have launched campaigns to take the White House. At AAHP, we are…
Read More